Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The factor V Leiden mutation in children with cancer and thrombosis.

British journal of haematology - 1 Mar 1997

Sifontes M T, Nuss R, Hunger S P, Wilimas J, Jacobson L J, Manco-Johnson M J

Abstract excerpt

Thromboembolic phenomena, frequently observed in children with cancer who are undergoing chemotherapy, can cause significant morbidity and, less frequently, mortality. Many contributory factors have been identified. Whether the recently identified and most common coagulation defect predisposing t...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Child
Share to Child, Preschool

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Infant

Share to Mutation

Share to Neoplasms

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 9054652
DOI: 10.1046/j.1365-2141.1997.d01-2046.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-9054652-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The factor V Leiden mutation in children with cancer and thrombosis.PMID 9054652Read ↗

Inherited thrombophilia and risk of thrombosis in children with cancer: a single-center experienceSemantic proximity Read ↗

Thrombotic complications during cancer treatment in children.Semantic proximity Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.Semantic proximity Read ↗

Prevalence of Factor V Leiden and other thrombophilic traits among Cretan children with malignancy.Semantic proximity Read ↗

Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.Semantic proximity Read ↗

Thrombophilia and cancer.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Thrombophilia and risk of venous thrombosis in patients with cancer.Semantic proximity Read ↗

Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters.Semantic proximity Read ↗

The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.